StockData
Whitehawk Therapeutics, Inc. logo

Whitehawk Therapeutics, Inc. (WHWK) stock

WHWKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30
$3.08+0.07 (+2.33%)

Close on Nov 17, 2026Market cap $175.59MP/E –Yield –

Whitehawk Therapeutics EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Whitehawk Therapeutics's EV/EBITDA was 4.3× on Jul 30, 2021.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2021Jul 30, 20214.3×–

More Whitehawk Therapeutics figures

See a number that looks wrong?